Histological grade, perineural infiltration, tumour-infiltrating lymphocytes and apoptosis as determinants of long-term prognosis in prostatic adenocarcinoma-Reference-Cited by-同舟云学术

Histological grade, perineural infiltration, tumour-infiltrating lymphocytes and apoptosis as determinants of long-term prognosis in prostatic adenocarcinoma

Published:1994-01 Issue:12 Volume:30 Page:1797-1803
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Vesalainen S.,Lipponen P.,Talja M.,Syrjänen K.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference35 articles.

1. Histologic grading and clinical staging of prostatic carcinoma;Gleason,1977

2. Flow cytometric analysis of DNA ploidy and S phase fraction from prostatic carcinomas: implications for prognosis and response to endocrine therapy;Visakorpi;Br J Cancer,1991

3. Nuclear deoxyribonucleic acid content measured by static cytometry: important prognostic association for patients with clinically localized prostate carcinoma treated by external beam radiotherapy;Song;J Urol,1992

4. Small subgroup of aggressive highly proliferative prostatic carcinomas defined by p53 accumulation;Visakorpi;J Natl Cancer Inst,1992

5. Relationship of proliferating cell nuclear antigen (PCNA) in prostatic carcinomas to various clinical parameters;Harper;Prostate,1992

Cited by 223 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dense tumor‐infiltrating lymphocytes (TILs) in liver metastasis from colorectal cancer are related to improved overall survival;Journal of Surgical Oncology;2024-07

2. Patterns of B‐cell lymphocyte expression changes in pre‐ and post‐malignant prostate tissue are associated with prostate cancer progression;Cancer Medicine;2024-03

3. Prognostic value of tumour-associated regulatory T-cells as a biomarker in non-small cell lung cancer: a systematic review and meta-analysis;2024-02-20

4. Basic Insights into Tumor Microenvironment in Prostate Cancer;Prostate Cancer;2024

5. Immune microenvironment of cervical cancer and the role of IL-2 in tumor promotion;Cytokine;2023-10